Alignment Healthcare, Inc.
ALHC
$16.35
-$0.02-0.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 42.17% | 46.40% | 47.58% | 49.69% | 49.34% |
| Total Other Revenue | 9.77% | 16.98% | 31.14% | 30.56% | 31.79% |
| Total Revenue | 41.81% | 46.06% | 47.39% | 49.46% | 49.12% |
| Cost of Revenue | 40.55% | 43.81% | 44.12% | 46.94% | 47.47% |
| Gross Profit | 51.38% | 64.23% | 75.37% | 70.60% | 63.01% |
| SG&A Expenses | 20.08% | 19.66% | 18.10% | 15.75% | 17.03% |
| Depreciation & Amortization | 12.58% | 13.44% | 8.46% | 16.82% | 21.30% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.75% | 40.34% | 40.21% | 42.09% | 42.56% |
| Operating Income | 158.79% | 116.50% | 105.36% | 84.07% | 54.41% |
| Income Before Tax | 121.82% | 99.25% | 87.67% | 68.64% | 42.31% |
| Income Tax Expenses | -42.86% | -4.76% | 32,640.00% | 162,300.00% | 282.61% |
| Earnings from Continuing Operations | 121.79% | 99.24% | 85.42% | 66.51% | 42.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -93.69% | 605.56% | 167.06% | 145.45% | 80.49% |
| Net Income | 121.85% | 99.43% | 85.56% | 66.65% | 42.37% |
| EBIT | 158.79% | 116.50% | 105.36% | 84.07% | 54.41% |
| EBITDA | 293.80% | 163.89% | 136.30% | 106.67% | 69.42% |
| EPS Basic | 120.83% | 99.37% | 85.35% | 66.89% | 43.50% |
| Normalized Basic EPS | 123.45% | 100.67% | 92.33% | 73.20% | 47.68% |
| EPS Diluted | 117.26% | 97.52% | 83.92% | 65.35% | 42.41% |
| Normalized Diluted EPS | 121.55% | 99.70% | 91.52% | 72.54% | 47.68% |
| Average Basic Shares Outstanding | 4.68% | 3.77% | 3.06% | 2.60% | 2.28% |
| Average Diluted Shares Outstanding | 8.44% | 6.53% | 5.84% | 4.08% | 2.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |